レジオネラ菌検査市場：検査、用途、エンドユーザー別-2025～2030年の世界予測

レジオネラ菌検査市場は、2023年に3億5,437万米ドルと評価され、2024年には3億8,586万米ドルに達すると予測され、CAGR 8.97%で成長し、2030年には6億4,696万米ドルに達すると予測されています。

レジオネラ菌検査は、重症の肺炎であるレジオネラ症を引き起こす可能性のあるレジオネラ菌の検出と定量化を含みます。この検査は、病院、ホテル、工業施設、住宅など、さまざまな環境における水の安全性を確保するために不可欠です。レジオネラ菌検査の必要性は、規制上の義務の増加、水性感染症に対する意識の高まり、公衆衛生と安全性に関する懸念の高まりによって強調されています。用途としては、主に日常的なサーベイランス、アウトブレイク調査、疾病のアウトブレイクを防ぐためのリスク評価などが挙げられます。エンドユーザーは医療、ホスピタリティ、製造業、政府機関など多岐にわたります。レジオネラ菌検査市場の主要成長要因としては、迅速PCRベースアッセイや新規イムノアッセイのような検査法の技術的発展、厳格な水質管理を要求するインフラ整備の進展などが挙げられます。市場開拓の機会があるのは新興経済諸国であり、そこではインフラ整備が堅調で、規制の枠組みも厳しくなっています。遠隔モニタリングソリューションの認知度向上と普及を促進するための地方行政機関とのパートナーシップは、市場参入をさらに拡大する可能性があります。しかし、先進的検査方法に伴う高コスト、地域による規制の違い、検出技術の標準化に関する問題などが制約となり、市場拡大の妨げとなる可能性があります。イノベーションの機会は、費用対効果が高く使いやすい検査キットの開発、IoTを利用したリアルタイム・モニタリングシステムの開発、除染のための潜在的生物製剤の探索に存在します。調査は、検査感度と特異度の向上、水システム管理における予測分析のためのAIと機械学習の統合に焦点を当てることができます。レジオネラ菌検査市場は競争的で成長しており、その動向は多くの水質問題に対処する、より包括的で統合されたソリューションに傾いています。利害関係者は、エンドユーザーや規制機関の進化するニーズを満たす画期的な製品を導入するために、戦略的な協力関係や研究開発への投資を優先すべきであり、それによって市場の持続的な成長が促進されます。

市場力学：急速に進化するレジオネラ菌検査市場の主要市場洞察を公開

レジオネラ菌検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • レジオネラ関連疾患の発生率の増加
  • 多くの産業における水質検査活動の重要性の高まり
  • 貯水池のモニタリングに関する厳しい規制
• 市場抑制要因
  • 診断検査の感度の問題
  • 検査に伴う高コスト
• 市場機会
  • レジオネラ菌検査における技術の進歩
  • 自己検査キットの出現
• 市場課題
  • 十分な診断インフラの欠如

ポーターのファイブフォース：レジオネラ菌検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：レジオネラ菌検査市場における外部からの影響の把握

外部マクロ環境要因は、レジオネラ菌検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：レジオネラ菌検査市場における競合情勢の把握

レジオネラ菌検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：レジオネラ菌検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、レジオネラ菌検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：レジオネラ菌検査市場における成功への道筋を描く

レジオネラ菌検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • レジオネラ関連疾患の発生率増加
    • 多くの産業で水質検査活動の重要性が高まっている
    • 貯水池のモニタリングに関する厳格な規制
  • 抑制要因
    • 診断検査の感度の問題
    • 検査にかかるコストが高い
  • 機会
    • レジオネラ菌検査における技術の進歩
    • 自己検査キットの登場
  • 課題
    • 十分な診断インフラの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 レジオネラ菌検査市場：検査別

• イントロダクション
• 培養方法
• 直接蛍光抗体検査
• 核酸ベースの検出
• 血清学
• 尿中抗原検査

第7章 レジオネラ菌検査市場：用途別

• イントロダクション
• 臨床検査
• 環境検査

第8章 レジオネラ菌検査市場：エンドユーザー別

• イントロダクション
• 診断ラボ
• 病院・クリニック

第9章 南北アメリカのレジオネラ菌検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のレジオネラ菌検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのレジオネラ菌検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Albagaia Ltd.
• Alere, Inc.
• Aquacert Ltd.
• Beckman Coulter, Inc.
• Becton, Dickinson, and Company
• Bio-Rad Laboratories, Inc
• bioMerieux SA
• Eiken Chemical Co., Ltd
• Hologic, Inc.
• IDEXX Laboratories, Inc.
• Merck KGaA
• PACIFIC WATER TECHNOLOGY PTY LTD
• Phigenics LLC
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. LEGIONELLA TESTING MARKET RESEARCH PROCESS
• FIGURE 2. LEGIONELLA TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. LEGIONELLA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LEGIONELLA TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LEGIONELLA TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT FLUORESCENT ANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY NUCLEIC ACID-BASED DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY URINARY ANTIGEN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CLINICAL TESTING METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 30. CANADA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 47. CHINA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 50. INDIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 102. ITALY LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 114. POLAND LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 117. QATAR LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM LEGIONELLA TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM LEGIONELLA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. LEGIONELLA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Legionella Testing Market was valued at USD 354.37 million in 2023, expected to reach USD 385.86 million in 2024, and is projected to grow at a CAGR of 8.97%, to USD 646.96 million by 2030.

Legionella testing involves the detection and quantification of Legionella bacteria, which can cause Legionnaires' disease, a severe form of pneumonia. The testing is essential for ensuring water safety in various settings such as hospitals, hotels, industrial facilities, and residential buildings. The necessity of Legionella testing has been underscored by increasing regulatory mandates, growing awareness of waterborne diseases, and rising concerns regarding public health and safety. Applications primarily involve routine surveillance, outbreak investigations, and risk assessments to prevent disease outbreaks. End-users span across healthcare, hospitality, manufacturing, and government sectors. Key growth factors for the Legionella testing market include technological advancements in testing methods, like rapid PCR-based assays and novel immunoassays, as well as increased infrastructure development that demands rigorous water quality management. Market opportunities lie in emerging economies where infrastructure development is robust, coupled with regulatory frameworks becoming more stringent. Partnerships with local governing bodies to promote awareness and the deployment of remote monitoring solutions can further expand market reach. However, limitations include high costs associated with advanced testing methods, regulatory variations across regions, and issues with the standardization of detection techniques that could hinder market expansion. Innovation opportunities exist in developing cost-effective and easy-to-use test kits, real-time monitoring systems using IoT, and exploring potential biologics for decontamination. Research efforts can focus on improving test sensitivity and specificity, as well as the integration of AI and machine learning for predictive analytics in water systems management. The Legionella testing market is competitive and growing, with the trend tilting towards more comprehensive, integrated solutions that address a multitude of water quality issues. Stakeholders should prioritize strategic collaborations and investment in R&D to introduce groundbreaking products that meet the evolving needs of end-users and regulatory bodies, thereby facilitating sustainable growth in the market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Legionella Testing Market

The Legionella Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of legionella-related disorders
  • Rising importance of water testing activities in many industries
  • Stringent regulations for monitoring water reservoirs
• Market Restraints
  • Issues in sensitivity of diagnostic tests
  • High cost associated with the test
• Market Opportunities
  • Technological advancement in legionella testing
  • Emergence of self-testing kits
• Market Challenges
  • Lack of sufficient diagnostic infrastructure

Porter's Five Forces: A Strategic Tool for Navigating the Legionella Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Legionella Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Legionella Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Legionella Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Legionella Testing Market

A detailed market share analysis in the Legionella Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Legionella Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Legionella Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Legionella Testing Market

A strategic analysis of the Legionella Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Legionella Testing Market, highlighting leading vendors and their innovative profiles. These include Albagaia Ltd., Alere, Inc., Aquacert Ltd., Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, bioMerieux SA, Eiken Chemical Co., Ltd, Hologic, Inc., IDEXX Laboratories, Inc., Merck KGaA, PACIFIC WATER TECHNOLOGY PTY LTD, Phigenics LLC, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Legionella Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test, market is studied across Culture Methods, Direct Fluorescent Antibody Test, Nucleic Acid-Based Detection, Serology, and Urinary Antigen Test.
• Based on Application, market is studied across Clinical Testing Methods and Environmental Testing Methods.
• Based on End-User, market is studied across Diagnostic Laboratories and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of legionella-related disorders
    • 5.1.1.2. Rising importance of water testing activities in many industries
    • 5.1.1.3. Stringent regulations for monitoring water reservoirs
  • 5.1.2. Restraints
    • 5.1.2.1. Issues in sensitivity of diagnostic tests
    • 5.1.2.2. High cost associated with the test
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in legionella testing
    • 5.1.3.2. Emergence of self-testing kits
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of sufficient diagnostic infrastructure
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Legionella Testing Market, by Test

• 6.1. Introduction
• 6.2. Culture Methods
• 6.3. Direct Fluorescent Antibody Test
• 6.4. Nucleic Acid-Based Detection
• 6.5. Serology
• 6.6. Urinary Antigen Test

7. Legionella Testing Market, by Application

• 7.1. Introduction
• 7.2. Clinical Testing Methods
• 7.3. Environmental Testing Methods

8. Legionella Testing Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospitals & Clinics

9. Americas Legionella Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Legionella Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Legionella Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Albagaia Ltd.
• 2. Alere, Inc.
• 3. Aquacert Ltd.
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson, and Company
• 6. Bio-Rad Laboratories, Inc
• 7. bioMerieux SA
• 8. Eiken Chemical Co., Ltd
• 9. Hologic, Inc.
• 10. IDEXX Laboratories, Inc.
• 11. Merck KGaA
• 12. PACIFIC WATER TECHNOLOGY PTY LTD
• 13. Phigenics LLC
• 14. Thermo Fisher Scientific, Inc.